Back to search

Article

High‐Throughput CRISPR/Cas9 Mediated Gene Editing of Primary Human T Cells in a Microfluidic Device for Cellular Therapy Manufacturing

2023-05-04

Abstract excerpt

Abstract Autologous cellular therapies have been highly successful in treating hematological cancers and have the potential to be used for a variety of indications. Manufacturing these therapies rapidly and at low cost remains a major challenge. A key bottleneck in cellular therapy manufacturing is genetic modification of target cells, which is often done using viral vectors. Because vectors are expensive to devel...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d6fe2efb-b621-58d5-b274-86b0695f9cde
DOI
10.1002/admt.202300275
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
High‐Throughput CRISPR/Cas9 Mediated Gene Editing of Primary Human T Cells in a Microfluidic Device for Cellular Therapy ManufacturingDOI 10.1002/admt.202300275
Select a neighboring publication to make it the new centre.